N/A
Completed N=128
Rivanna Ultrasound for Neuraxial Block
Analgesia
Source: ClinicalTrials.gov NCT03214640 ↗
Enrolled (actual)
128
Serious AEs
0.0%
Results posted
Jul 2021
Primary outcomePrimary: Time to Success of Neuraxial Block Placement — 122; 111; 50; 78.5 seconds
Summary
We hypothesize that the Rivanna Accuro or similar U/S device would reduce time to success of identifying epidural and/or intrathecal spaces as compared to conventional palpation method.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Time to Success of Neuraxial Block Placement |
122; 111; 50; 78.5 | — |
| SECONDARY Total Number of Needle Passes Per Placement |
2; 1; 1; 1 | — |
| SECONDARY Needle Passing Success at First Attempt |
10; 18; 18; 24 | — |
Eligibility Criteria
Inclusion Criteria
- BMI >30
- Female requesting analgesia for delivery, be it via vaginal or cesarean delivery
Exclusion Criteria
- Allergy to ultrasound gel
- Contraindication to receiving neuraxial analgesia
- Under the age of 18
Data sourced from ClinicalTrials.gov (NCT03214640). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.